Obesity hypertension: The regulatory role of leptin

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Kshatriya, Shilpa ^a   Liu, Kan ^a   Salah, Ali ^a   Szombathy, Tamas ^a   Freeman, Ronald H ^b   Reams, Garry P ^b   Spear, Robert M ^a   Villarreal, Daniel ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HORMONE RECEPTOR BLOCKING AGENT; LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR BLOCKING AGENT; SODIUM; UNCLASSIFIED DRUG;

ADIPOCYTE; ADRENERGIC SYSTEM; BLOOD PRESSURE REGULATION; CARDIOMEGALY; CELLULAR DISTRIBUTION; CHRONIC KIDNEY FAILURE; CREATININE CLEARANCE; DISEASE ASSOCIATION; DRUG TARGETING; ENERGY METABOLISM; GENE; GENE FUNCTION; GENE LOCATION; GENETIC VARIABILITY; HEART INFARCTION; HORMONE ACTION; HUMAN; HYPERLEPTINEMIA; HYPERTENSION; IRS 1 GENE; LEPR GENE; LEPTIN RESISTANCE; LOSS OF FUNCTION MUTATION; LUNG PARENCHYMA; MC4R GENE; MEAN ARTERIAL PRESSURE; METABOLIC DISORDER; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; REGULATORY MECHANISM; REVIEW; RNA SPLICING; SIGNAL TRANSDUCTION; SOCS3 GENE; SODIUM BLOOD LEVEL; SODIUM METABOLISM; TISSUE DISTRIBUTION;

EID: 80054993102     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/270624     Document Type: Review

References (101)

1. Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M., Prevalence of overweight and obesity in the United States, 19992004. Journal of the American Medical Association 2006 295 13 1549 1555 2-s2.0-33645523067 10.1001/jama.295.13.1549
2. Hall J. E., Crook E. D., Jones D. W., Wofford M. R., Dubbert P. M., Mechanisms of obesity-associated cardiovascular and renal disease. American Journal of the Medical Sciences 2002 324 3 127 137 2-s2.0-0036745457
3. Hajer G. R., Van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
4. Garrison R. J., Kannel W. B., Stokes J., Castelli W. P., Incidence and precursors of hypertension in young adults: the Framingham offspring study. Preventive Medicine 1987 16 2 235 251 2-s2.0-0023204243 (Pubitemid 17067798)
5. Wofford M. R., Hall J. E., Pathophysiology and treatment of obesity hypertension. Current Pharmaceutical Design 2004 10 29 3621 3637 2-s2.0-6344226830 10.2174/1381612043382855 (Pubitemid 39386578)
6. Hutley L., Prins J. B., Fat as an endocrine organ: relationship to the metabolic syndrome. American Journal of the Medical Sciences 2005 330 6 280 289 2-s2.0-29244465117 (Pubitemid 41831898)
7. Guha P. K., Villarreal D., Reams G. P., Freeman R. H., Role of leptin in the regulation of body fluid volume and pressures. American Journal of Therapeutics 2003 10 3 211 218 2-s2.0-0141542617
8. Sharma V., McNeill J. H., The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology. Current Vascular Pharmacology 2005 3 2 169 180 2-s2.0-18044394757 10.2174/1570161053586868 (Pubitemid 40601585)
9. Misra A., Garg A., Leptin, its receptor and obesity. Journal of Investigative Medicine 1996 44 9 540 548 2-s2.0-0030331944 (Pubitemid 126820702)
10. Lönnqvist F., The obese (ob) gene and its product leptina new route toward obesity treatment in man? Monthly Journal of the Association of Physicians 1996 89 5 327 332 2-s2.0-0029994280
11. Betowski J., Role of leptin in blood pressure regulation and arterial hypertension. Journal of Hypertension 2006 24 5 789 801 2-s2.0-33646360219 10.1097/01.hjh.0000222743.06584.66 (Pubitemid 43670444)
12. Haynes W. G., Morgan D. A., Walsh S. A., Mark A. L., Sivitz W. I., Receptor-mediated regional sympathetic nerve activation by leptin. Journal of Clinical Investigation 1997 100 2 270 278 2-s2.0-0030876805 (Pubitemid 27349073)
13. Dunbar J. C., Hu Y., Lu H., Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997 46 12 2040 2043 2-s2.0-0030830662 (Pubitemid 27512093)
14. Villarreal D., Reams G., Freeman R. H., Taraben A., Renal effects of leptin in normotensive, hypertensive, and obese rats. American Journal of Physiology 1998 275 6 R2056 R2060 2-s2.0-0032440815
15. Chen H., Charlat O., Tartaglia L. A., Woolf E. A., Weng X., Ellis S. J., Lakey N. D., Culpepper J., More K. J., Breitbart R. E., Duyk G. M., Tepper R. I., Morgenstern J. P., Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996 84 3 491 495 2-s2.0-13344259300 10.1016/S0092-8674(00)81294-5 (Pubitemid 26060722)
16. Banks A. S., Davis S. M., Bates S. H., Myers M. G., Activation of downstream signals by the long form of the leptin receptor. Journal of Biological Chemistry 2000 275 19 14563 14572 2-s2.0-0034640508 10.1074/jbc.275.19.14563 (Pubitemid 30339746)
17. Münzberg H., Myers M. G., Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience 2005 8 5 566 570 2-s2.0-17844401180 10.1038/nn1454 (Pubitemid 40594195)
18. Tartaglia L. A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G. J., Campfield L. A., Clark F. T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K. J., Smutko J. S., Mays G. G., Woolf E. A., Monroe C. A., Tepper R. I., Identification and expression cloning of a leptin receptor, OB-R. Cell 1995 83 7 1263 1271 2-s2.0-2442654859 10.1016/0092-8674(95)90151-5 (Pubitemid 26007816)
19. Wang M. Y., Zhou Y. T., Newgard C. B., Unger R. H., A novel leptin receptor isoform in rat. FEBS Letters 1996 392 2 87 90 2-s2.0-0030603159 10.1016/0014-5793(96)00790-9 (Pubitemid 26276724)
20. Hoggard N., Mercer J. G., Rayner D. V., Moar K., Trayhurn P., Williams L. M., Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochemical and Biophysical Research Communications 1997 232 2 383 387 2-s2.0-0031575804 10.1006/bbrc.1997.6245 (Pubitemid 27216224)
21. Anubhuti V., Arora S., Leptin and its metabolic interactionsan update. Diabetes, Obesity and Metabolism 2008 10 11 973 993 2-s2.0-54249106761 10.1111/j.1463-1326.2008.00852.x
22. Mark A. L., Agassandian K., Morgan D. A., Liu X., Cassell M. D., Rahmouni K., Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension 2009 53 2 375 380 2-s2.0-59849116907 10.1161/HYPERTENSIONAHA.108.124255
23. Ozata M., Ozdemir I. C., Licinio J., Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. Journal of Clinical Endocrinology and Metabolism 1999 84 10 3686 3695 2-s2.0-0033304576 (Pubitemid 30645226)
24. Betowski J., Jochem J., Wójcicka G., Zwirska-Korczala K., Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. Regulatory Peptides 2004 120 13 59 67 2-s2.0-2642533424 10.1016/j.regpep.2004.02.012 (Pubitemid 38726192)
25. Lembo G., Vecchione C., Fratta L., Marino G., Trimarco V., D'Amati G., Trimarco B., Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000 49 2 293 297 2-s2.0-0033978467 (Pubitemid 30071008)
26. Frühbeck G., Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999 48 4 903 908 2-s2.0-0037907471 (Pubitemid 29153093)
27. Brook R. D., Bard R. L., Bodary P. F., Eitzman D. T., Rajagopalan S., Sun Y., Depaoli A. M., Blood pressure and vascular effects of leptin in humans. Metabolic Syndrome and Related Disorders 2007 5 3 270 274 2-s2.0-34548622624 10.1089/met.2006.0023
28. Mitchell J. L., Morgan D. A., Correia M. L. G., Mark A. L., Sivitz W. I., Haynes W. G., Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation? Hypertension 2001 38 5 1081 1086 2-s2.0-0035725056 (Pubitemid 34252809)
29. Gardiner S. M., Kemp P. A., March J. E., Bennett T., Regional haemodynamic effects of recombinant murine or human leptin in conscious rats. British Journal of Pharmacology 2000 130 4 805 810 2-s2.0-0034121709 (Pubitemid 30389059)
30. Betowski J., Wójcicka G., Jamroz-Wiśniewska A., Marciniak A., Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome. Life Sciences 2009 85 15-16 557 567 2-s2.0-70349292060 10.1016/j.lfs.2009.08.002
31. Mark A. L., Shaffer R. A., Correia M. L. G., Morgan D. A., Sigmund C. D., Haynes W. G., Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. Journal of Hypertension 1999 17 12 1949 1953 2-s2.0-0033512117 (Pubitemid 30345336)
32. Correia M. L. G., Haynes W. G., Rahmouni K., Morgan D. A., Sivitz W. I., Mark A. L., The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002 51 2 439 442 2-s2.0-0036066483 (Pubitemid 34764800)
33. Morgan D. A., Thedens D. R., Weiss R., Rahmouni K., Mechanisms mediating renal sympathetic activation to leptin in obesity. American Journal of Physiology 2008 295 6 R1730 R1736 2-s2.0-57749112002 10.1152/ajpregu.90324.2008
34. Rahmouni K., Correia M. L. G., Haynes W. G., Mark A. L., Obesity-associated hypertension: New insights into mechanisms. Hypertension 2005 45 1 9 14 2-s2.0-11244349747 10.1161/01.HYP.0000151325.83008.b4 (Pubitemid 40066405)
35. Tune J. D., Considine R. V., Effects of leptin on cardiovascular physiology. Journal of the American Society of Hypertension 2007 1 4 231 241 2-s2.0-34447624673 10.1016/j.jash.2007.04.001 (Pubitemid 47091544)
36. Bjorbaek C., Elmquist J. K., Frantz J. D., Shoelson S. E., Flier J. S., Identification of SOCS-3 as a potential mediator of central leptin resistance. Molecular Cell 1998 1 4 619 625 2-s2.0-0032014178 (Pubitemid 128374698)
37. Shek E. W., Brands M. W., Hall J. E., Chronic leptin infusion increases arterial pressure. Hypertension 1998 31 1 409 414 2-s2.0-0031606279
38. Huang F., Xiong X., Wang H., You S., Zeng H., Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF- κ B. Acta Biochimica et Biophysica Sinica 2010 42 5 325 331 2-s2.0-77951833234 10.1093/abbs/gmq025
39. Galletti F., D'Elia L., Barba G., Siani A., Cappuccio F. P., Farinaro E., Iacone R., Russo O., De Palma D., Ippolito R., Strazzullo P., High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study. Journal of Clinical Endocrinology and Metabolism 2008 93 10 3922 3926 2-s2.0-53749097600 10.1210/jc.2008-1280
40. Ma D., Feitosa M. F., Wilk J. B., Laramie J. M., Yu K., Leiendecker-Foster C., Myers R. H., Province M. A., Borecki I. B., Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute family heart study. Hypertension 2009 53 3 473 479 2-s2.0-61749084673 10.1161/HYPERTENSIONAHA.108.118133
41. Shankar A., ashankar@hsc.wvu.edu Xiao J., Positive relationship between plasma leptin level and hypertension. Hypertension 2010 56 4 623 628 10.1161/HYPERTENSIONAHA.109.148213
42. Fogari R., Derosa G., Zoppi A., Rinaldi A., Lazzari P., Fogari E., Mugellini A., Preti P., Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertension Research 2005 28 3 209 214 2-s2.0-20444479426 10.1291/hypres.28.209 (Pubitemid 40812604)
43. Santos E. L., de Picoli Souza K., da Silva E. D., Batista E. C., Martins P. J. F., D'Almeida V., Pesquero J. B., Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochemical Pharmacology 2009 78 8 951 958 2-s2.0-69549095825 10.1016/j.bcp.2009.06.018
44. Haynes W. G., Morgan D. A., Djalali A., Sivitz W. I., Mark A. L., Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999 33 1, part 2 542 547 2-s2.0-0032899719 (Pubitemid 29065717)
45. Rahmouni K., Haynes W. G., Morgan D. A., Mark A. L., Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. Journal of Neuroscience 2003 23 14 5998 6004 2-s2.0-0038149085 (Pubitemid 36859438)
46. Greenfield J. R., Miller J. W., Keogh J. M., Henning E., Satterwhite J. H., Cameron G. S., Astruc B., Mayer J. P., Brage S., See T. C., Lomas D. J., O'Rahilly S., Farooqi I. S., Modulation of blood pressure by central melanocortinergic pathways. New England Journal of Medicine 2009 360 1 44 52 2-s2.0-58249087146 10.1056/NEJMoa0803085
47. Serradeil-Le Gal C., Raufaste D., Brossard G., Pouzet B., Marty E., Maffrand J. P., Le Fur G., Characterization and localization of leptin receptors in the rat kidney. FEBS Letters 1997 404 2-3 185 191 2-s2.0-0031052428 10.1016/S0014-5793(97)00125-7 (Pubitemid 27113450)
48. Jackson E. K., Li P., Human leptin has natriuretic activity in the rat. American Journal of Physiology 1997 272 3 F333 F338 2-s2.0-0030771886
49. Villarreal D., Reams G., Freeman R. H., Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats. Kidney International 2000 58 3 989 994 2-s2.0-0033849818 10.1046/j.1523-1755.2000. 00256.x
50. DiBona G. F., The kidney in the pathogenesis of hypertension: the role of renal nerves. American Journal of Kidney Diseases 1985 5 4 A27 A31 2-s2.0-0021917564
51. Patel S., Villarreal D., Kundra A., Cardiovascular and renal actions of leptin. Cardiac Hormones 2008 111 127
52. Betowski J., Wójcicka G., Górny D., Marciniak A., Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na, K-ATPase activity in the ratimpaired effect in dietary-induced obesity. Medical Science Monitor 2002 8 6 BR221 BR229 2-s2.0-0036280459 (Pubitemid 34694643)
53. Villarreal D., Reams G., Samar H., Spear R., Freeman R. H., Effects of chronic nitric oxide inhibition on the renal excretory response to leptin. Obesity Research 2004 12 6 1006 1010 2-s2.0-4644363328 (Pubitemid 41202403)
54. Lin L., Martin R., Schaffhauser A. O., York D. A., Acute changes in the response to peripheral leptin with alteration in the diet composition. American Journal of Physiology 2001 280 2 R504 R509 2-s2.0-0034999480
55. Bouloumié A., Marumo T., Lafontan M., Busse R., Leptin induces oxidative stress in human endothelial cells. FASEB Journal 1999 13 10 1231 1238 2-s2.0-0032999682 (Pubitemid 29300368)
56. Dobrian A. D., Schriver S. D., Lynch T., Prewitt R. L., Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. American Journal of Physiology 2003 285 4 F619 F628 2-s2.0-0141478841 (Pubitemid 37140246)
57. Adamczak M., Kokot F., Chudek J., Wiecek A., Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension. Medical Science Monitor 2002 8 7 CR473 CR477 (Pubitemid 34826766)
58. Wolf G., Ziyadeh F. N., Leptin and renal fibrosis. Contributions to Nephrology 2006 151 175 183 2-s2.0-33748062001 10.1159/000095328 (Pubitemid 44298231)
59. Wolf G., Chen S., Han D. C., Ziyadeh F. N., Leptin and renal disease. American Journal of Kidney Diseases 2002 39 1 1 11 2-s2.0-0036144209 (Pubitemid 34062489)
60. Deji N., Kume S., Araki S. I., Soumura M., Sugimoto T., Isshiki K., Chin-Kanasaki M., Sakaguchi M., Koya D., Haneda M., Kashiwagi A., Uzu T., Structural and functional changes in the kidneys of high-fat diet-induced obese mice. American Journal of Physiology 2009 296 1 F118 F126 2-s2.0-58849141672 10.1152/ajprenal.00110.2008
61. Gannagé-Yared M. H., Khalife S., Semaan M., Fares F., Jambart S., Halaby G., Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. European Journal of Endocrinology 2006 155 1 167 176 2-s2.0-33746317151 10.1530/eje.1.02175 (Pubitemid 44103386)
62. Sharma K., Considine R. V., Michael B., Dunn S. R., Weisberg L. S., Kurnik B. R. C., Kurnik P. B., O'Connor J., Sinha M., Caro J. F., Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney International 1997 51 6 1980 1985 2-s2.0-8244232511 (Pubitemid 27252771)
63. Nordfors L., Lönnqvist F., Heimbürger O., Danielsson A., Schalling M., Stenvinkel P., Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney International 1998 54 4 1267 1275 2-s2.0-0031708589 10.1046/j.1523-1755.1998.00088.x (Pubitemid 28449914)
64. Stenvinkel P., Lönnqvist F., Schalling M., Molecular studies of leptin: implications for renal disease. Nephrology Dialysis Transplantation 1999 14 5 1103 1112 2-s2.0-0344052672 10.1093/ndt/14.5.1103 (Pubitemid 29209292)
65. Heimbürger O., Lönnqvist F., Danielsson A., Nordenström J., Stenvinkel P., Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. Journal of the American Society of Nephrology 1997 8 9 1423 1430 2-s2.0-0142203432 (Pubitemid 27491233)
66. Cumin F., Baum H.-P., De Gasparo M., Levens N., Removal of endogenous leptin from the circulation by the kidney. International Journal of Obesity 1997 21 6 495 504 (Pubitemid 27236969)
67. Johansen K. L., Mulligan K., Tai V., Schambelan M., Leptin, body composition, and indices of malnutrition in patients on dialysis. Journal of the American Society of Nephrology 1998 9 6 1080 1084 2-s2.0-0031778958 (Pubitemid 28264736)
68. Stenvinkel P., Heimbürger O., Lönnqvist F., Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrology Dialysis Transplantation 1997 12 7 1321 1325 2-s2.0-0030757328 10.1093/ndt/12.7.1321 (Pubitemid 27353018)
69. Fontan M. P., Rodriguez-Carmona A., Cordido F., Garcia-Buela J., Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. American Journal of Kidney Diseases 1999 34 5 824 831 2-s2.0-0032710780 (Pubitemid 29521697)
70. Bossola M., Tazza L., Giungi S., Luciani G., Anorexia in hemodialysis patients: an update. Kidney International 2006 70 3 417 422 2-s2.0-33746578399 10.1038/sj.ki.5001572 (Pubitemid 44141567)
71. Stenvinkel P., Lindholm B., Lönnqvist F., Katzarski K., Heimbürger O., Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. Journal of the American Society of Nephrology 2000 11 7 1303 1309 2-s2.0-0034042923 (Pubitemid 30416227)
72. Odamaki M., Furuya R., Yoneyama T., Nishikino M., Hibi I., Miyaji K., Kumagai H., Association of the serum leptin concentration with weight loss in chronic hemodialysis patients. American Journal of Kidney Diseases 1999 33 2 361 368 2-s2.0-0032965562 (Pubitemid 29072241)
73. Mak R. H., Cheung W., Cone R. D., Marks D. L., Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney International 2006 69 5 794 797 2-s2.0-33644554532 10.1038/sj.ki.5000182
74. Cheung W., Yu P. X., Little B. M., Cone R. D., Marks D. L., Mak R. H., Role of leptin and melanocortin signaling in uremia-associated cachexia. Journal of Clinical Investigation 2005 115 6 1659 1665 2-s2.0-20444497662 10.1172/JCI22521 (Pubitemid 40814675)
75. Axelsson J., Qureshi A. R., Heimbürger O., Lindholm B., Stenvinkel P., Bárány P., Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. American Journal of Kidney Diseases 2005 46 4 628 634 2-s2.0-25644444060 10.1053/j.ajkd.2005.06.004 (Pubitemid 41383940)
76. Hung S. C., Tung T. Y., Yang C. S., Tarng D. C., High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients. American Journal of Kidney Diseases 2005 45 6 1073 1083 2-s2.0-20444419806 10.1053/j.ajkd.2005.02.020 (Pubitemid 40806521)
77. Coen G., Ballanti P., Fischer M. S., Balducci A., Calabria S., Colamarco L., Di Zazzo G., Lifrieri F., Manni M., Sardella D., Nofroni I., Bonucci E., Serum leptin in dialysis renal osteodystrophy. American Journal of Kidney Diseases 2003 42 5 1036 1042 2-s2.0-10744220420 (Pubitemid 37322920)
78. Mallamaci F., Tripepi G., Zoccali C., Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. Journal of Nephrology 2005 18 4 464 468 2-s2.0-28244453361 (Pubitemid 41700115)
79. Zoccali C., Mallamaci F., Tripepi G., Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney International, Supplement 2003 63 84 S65 S68 2-s2.0-0037406416 (Pubitemid 36513378)
80. Emilsson V., Liu Y. L., Cawthorne M. A., Morton N. M., Davenport M., Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997 46 2 313 316 2-s2.0-0030965884 (Pubitemid 27272267)
81. Konstantinides S., Schäfer K., Koschnick S., Loskutoff D. J., Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. Journal of Clinical Investigation 2001 108 10 1533 1540 2-s2.0-0035179087 10.1172/JCI200113143 (Pubitemid 33091991)
82. Sierra-Honigmann M. R., Nath A. K., Murakami C., García- Cardeña G., Papapetropoulos A., Sessa W. C., Madge L. A., Schechner J. S., Schwabb M. B., Polverini P. J., Flores-Riveros J. R., Biological action of leptin as an angiogenic factor. Science 1998 281 5383 1683 1686 2-s2.0-0032508682 10.1126/science.281.5383.1683 (Pubitemid 28435586)
83. Singh P., Hoffmann M., Wolk R., Shamsuzzaman A. S. M., Somers V. K., Leptin induces C-reactive protein expression in vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 9 e302 e307 2-s2.0-34548151859 10.1161/ATVBAHA.107.148353 (Pubitemid 47312298)
84. Romero-Corral A., Sierra-Johnson J., Lopez-Jimenez F., Thomas R. J., Singh P., Hoffmann M., Okcay A., Korinek J., Wolk R., Somers V. K., Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nature Clinical Practice Cardiovascular Medicine 2008 5 7 418 425 2-s2.0-46649113125 10.1038/ncpcardio1218 (Pubitemid 351935576)
85. Karmazyn M., Purdham D. M., Rajapurohitam V., Zeidan A., Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends in Cardiovascular Medicine 2007 17 6 206 211 2-s2.0-34447643051 10.1016/j.tcm.2007.06.001 (Pubitemid 47089011)
86. Rajapurohitam V., Gan X. T., Kirshenbaum L. A., Karmazyn M., The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circulation Research 2003 93 4 277 279 2-s2.0-0041857804 10.1161/01.RES.0000089255.37804.72 (Pubitemid 37048239)
87. Selthofer-Relatić K., Radić R., Vizjak V., Včev A., Kosović P., Bošnjak I., Selthofer R., Hyperleptinemianon- haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females. Collegium Antropologicum 2008 32 3 681 685 2-s2.0-53549106062
88. Umemoto Y., Tsuji K., Yang F. C., Ebihara Y., Kaneko A., Furukawa S., Nakahata T., Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood 1997 90 9 3438 3443 2-s2.0-0030736770 (Pubitemid 27473413)
89. Paolisso G., Tagliamonte M. R., Galderisi M., Zito G. A., Petrocelli A., Carella C., De Divitiis O., Varricchio M., Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 1999 34 5 1047 1052 2-s2.0-0032707747
90. Leyva F., Anker S. D., Egerer K., Stevenson J. C., Kox W. J., Coats A. J. S., Hyperleptinaemia in chronic heart failure. Relationships with insulin. European Heart Journal 1998 19 10 1547 1551 2-s2.0-0032189670 10.1053/euhj.1998.1045 (Pubitemid 28470477)
91. Purdham D. M., Rajapurohitam V., Zeidan A., Huang C., Gross G. J., Karmazyn M., A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. American Journal of Physiology 2008 295 1 H441 H446 2-s2.0-49849103205 10.1152/ajpheart.91537.2007
92. Rajapurohitam V., Javadov S., Purdham D. M., Kirshenbaum L. A., Karmazyn M., An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. Journal of Molecular and Cellular Cardiology 2006 41 2 265 274 2-s2.0-33746093293 10.1016/j.yjmcc.2006.05.001 (Pubitemid 44080214)
93. Nagae AI., Fujita M., Kawarazaki H., Matsui H., Ando K., Fujita T., Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 2009 119 7 978 986 2-s2.0-61849153939 10.1161/CIRCULATIONAHA.108.824730
94. Abe Y., Ono K., Kawamura T., Wada H., Kita T., Shimatsu A., Hasegawa K., Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation. American Journal of Physiology 2007 292 5 H2387 H2396 2-s2.0-34250891864 10.1152/ajpheart.00579.2006 (Pubitemid 47084621)
95. Mcgaffin K. R., Zou B., Mctiernan C. F., O'donnell C. P., Leptin attenuates cardiac apoptosis after chronic ischaemic injury. Cardiovascular Research 2009 83 2 313 324 2-s2.0-67650257499 10.1093/cvr/cvp071
96. Barouch L. A., Berkowitz D. E., Harrison R. W., O'Donnell C. P., Hare J. M., Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003 108 6 754 759 2-s2.0-0042018759 10.1161/01.CIR.0000083716.82622.FD (Pubitemid 36999263)
97. Tajmir P., Ceddia R. B., Li R. K., Coe I. R., Sweeney G., Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology 2004 145 4 1550 1555 2-s2.0-1642464978 10.1210/en.2003-1128 (Pubitemid 38402359)
98. Nickola M. W., Wold L. E., Colligan P. B., Wang G. J., Samson W. K., Ren J., Leptin attenuates cardiac contraction in rat ventricular myocytes role of NO. Hypertension 2000 36 4 501 505 2-s2.0-0033775092
99. Luo J. D., Zhang G. S., Chen M. S., Leptin and cardiovascular diseases. Drug News and Perspectives 2005 18 7 427 431 2-s2.0-29044436078 10.1358/dnp.2005.18.7.939346 (Pubitemid 41789101)
100. Tritos N. A., Manning W. J., Danias P. G., Role of leptin in the development of cardiac hypertrophy in experimental animals and humans. Circulation 2004 109 7 e67 2-s2.0-2442696860
101. Schulze P. C., Kratzsch J., Linke A., Schoene N., Adams V., Gielen S., Erbs S., Moebius-Winkler S., Schuler G., Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. European Journal of Heart Failure 2003 5 1 33 40 2-s2.0-12244309089 10.1016/S1388-9842(02)00177-0 (Pubitemid 36205542)